Alumis ALMS
NASDAQ ALMS
$11.17 -0.19 (-1.67%)
As of: Sep 4, 2026 · 2:34 PM EDT

Alumis (ALMS) Change in Account Payables (2023 - 2025)

Alumis (ALMS) posted quarterly Change in Account Payables of $5.6 million for Q4 2025, up 74.31% year-over-year from $3.2 million in Q4 2024, and up 153.24% quarter-over-quarter from -$10.4 million in Q3 2025.

Analysis

Alumis (ALMS) Change in Account Payables (2023 - 2025) Analysis & Trends

Alumis (ALMS) has reported Change in Account Payables for 3 consecutive years, with $5.6 million the latest figure, recorded in Q4 2025.

  • In Q4 2025, Change in Account Payables rose 74.31% year-over-year to $5.6 million; the TTM figure through Dec 2025 stood at -$6.0 million (down 170.96% YoY), while the FY2025 annual figure was -$6.0 million, down 170.96% from the prior year.
  • Change in Account Payables advanced to $5.6 million in Q4 2025 per ALMS's latest filing, from -$10.4 million in the prior quarter.
  • Across five years, Change in Account Payables topped out at $5.7 million in Q1 2024 and bottomed at -$10.4 million in Q3 2025.
  • Historically, Change in Account Payables has averaged $116200.0 across 3 years, with a median of $1.5 million in 2023.
  • Annual changes were most pronounced in 2024 — Change in Account Payables soared 196.87% — and 2025, when it slumped 322.71%.
  • Alumis' Change in Account Payables stood at -$3.3 million in 2023, then jumped by 196.87% to $3.2 million in 2024, then soared by 74.31% to $5.6 million in 2025.
  • Business Quant data shows ALMS's Change in Account Payables at $5.6 million in Q4 2025, -$10.4 million in Q3 2025, and $989000.0 in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Vertex Pharmaceuticals 138.77 Bn 130.92 Bn 2.84 Bn -66.70 Mn
2 Regeneron Pharmaceuticals 85.51 Bn 77.52 Bn 3.93 Bn -
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn -
4 Moderna 58.20 Bn 53.06 Bn 52.00 Mn -8.00 Mn
5 Revolution Medicines 44.04 Bn 44.04 Bn - 5.03 Mn
6 BeOne Medicines 39.99 Bn 34.89 Bn 1.53 Bn 37.53 Mn
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn -
8 Royalty Pharma 28.40 Bn 27.56 Bn - -
9 Insmed 27.44 Bn 26.28 Bn 358.27 Mn -
10 Alumis 1.43 Bn 924.11 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 5.55 Mn
Sep 30, 2025 -10.42 Mn
Jun 30, 2025 989,000.00
Mar 31, 2025 -2.15 Mn
Dec 31, 2024 3.18 Mn
Sep 30, 2024 -2.47 Mn
Jun 30, 2024 2.07 Mn
Mar 31, 2024 5.72 Mn
Dec 31, 2023 -3.29 Mn
Sep 30, 2023 1.98 Mn